Iain Stuart

Iain Stuart

Company: Vyne Therapeutics

Job title: Chief Scientific Officer

Seminars:

The InhiBETTM Platform: Bromodomain and End Terminal (BET) Inhibitors in Autoimmune Disease 11:00 am

Review BET protein antagonism and MoA in autoimmune disease, what have we learned? Explore drug design and disposition strategies to optimize benefit/risk of BET inhibitors Introducing VYN201, a highly potent BD1/BD2 BET protein inhibitor, for locallyacting treatment of major immuno-inflammatoryRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.